Premarket trading runs 4:00 AM – 9:30 AM ET.
BBIO last traded at $84.22 in premarket, up $3.92 (4.88%) from its previous close of $80.30.
📅 BBIO is scheduled to report earnings on Aug 4, 2026 after the close (confirmed), with an estimated EPS of $-0.64. BBIO earnings details →
Over the past 5 years, BBIO has had 33 qualifying gap events (gaps of 5% or more at the open) — 21 gap-ups and 12 gap-downs. Gap-ups averaged +13.2%, 71% have fully filled, median time to fill 2 trading days. Gap-downs averaged -12.3%, 83% have fully filled, median time to fill 4.5 trading days. Most recent: a +7.2% gap up 9 days ago, still unfilled. BBIO has 1 unfilled gap from the past 60 days — a +7.2% gap up on Jul 9, 2026, currently 89% retraced. Average 20-trading-day return after a BBIO gap up: -3.3%. After a gap down: +11.79%.
| 1 day | 1 week | 2 week | 4 week | |
|---|---|---|---|---|
| fills 25% | 57% | 76% | 81% | 90% |
| fills 50% | 48% | 71% | 76% | 90% |
| fills 75% | 33% | 52% | 62% | 86% |
| fills 100% | 24% | 52% | 57% | 71% |
| 1 day | 1 week | 2 week | 4 week | |
|---|---|---|---|---|
| fills 25% | 75% | 92% | 92% | 92% |
| fills 50% | 42% | 83% | 92% | 92% |
| fills 75% | 25% | 67% | 83% | 92% |
| fills 100% | 17% | 50% | 50% | 83% |
| Date | Gap From | Gap % | Status | Days to 50% | Days to Fill | % of Gap Filled After | |||
|---|---|---|---|---|---|---|---|---|---|
| 1 day | 1 week | 2 week | 4 week | ||||||
| 9 days ago | $78.33 | +7.24% | Open | 6d | — | 0% | 68% | 89% | 89% |
| 2026-04-28 | $74.52 | +11.65% | Filled | 1d | 1d | 100% | 100% | 100% | 100% |
| 2026-02-12 | $73.33 | +15.70% | Filled | 1d | 2d | 77% | 100% | 100% | 100% |
| 2026-02-06 | $63.73 | +9.96% | Filled | 13d | 13d | 39% | 39% | 47% | 100% |
| 2025-10-29 | $64.50 | +7.55% | Filled | 1d | 1d | 100% | 100% | 100% | 100% |
| 2025-10-27 | $54.26 | +5.05% | Open | — | — | 9% | 9% | 9% | 9% |
| 2025-08-06 | $49.21 | -9.57% | Filled | 3d | 6d | 29% | 100% | 100% | 100% |
| 2025-04-30 | $36.42 | +6.01% | Filled | 1d | 5d | 63% | 100% | 100% | 100% |
| 2025-04-07 | $31.37 | -5.90% | Filled | 1d | 1d | 100% | 100% | 100% | 100% |
| 2025-03-06 | $34.97 | -7.06% | Filled | 10d | 12d | 38% | 38% | 85% | 100% |
| 2025-02-25 | $36.25 | -5.71% | Filled | 1d | 20d | 62% | 62% | 62% | 100% |
| 2025-02-20 | $36.29 | +8.57% | Filled | 1d | 1d | 100% | 100% | 100% | 100% |
| 2024-11-25 | $23.42 | +23.01% | Open | 2d | — | 36% | 61% | 61% | 64% |
| 2024-08-30 | $24.62 | +5.61% | Filled | 17d | 17d | 11% | 11% | 11% | 100% |
| 2024-08-05 | $26.18 | -7.75% | Filled | 1d | 16d | 79% | 79% | 79% | 100% |
| 2024-08-02 | $26.18 | -6.64% | Filled | 1d | 1d | 100% | 100% | 100% | 100% |
| 2024-06-24 | $27.36 | -11.26% | Filled | 5d | 13d | 14% | 59% | 81% | 100% |
| 2024-06-04 | $28.98 | +8.07% | Filled | 1d | 1d | 100% | 100% | 100% | 100% |
| 2024-02-15 | $34.37 | +9.83% | Filled | 3d | 4d | 7% | 100% | 100% | 100% |
| 2024-02-13 | $35.65 | -5.47% | Filled | 1d | 3d | 71% | 100% | 100% | 100% |
| 2023-11-14 | $27.52 | +6.14% | Open | 6d | — | 25% | 68% | 68% | 87% |
| 2023-10-24 | $24.24 | +5.73% | Filled | 1d | 2d | 65% | 100% | 100% | 100% |
| 2023-07-17 | $18.22 | +46.87% | Open | — | — | 6% | 6% | 6% | 6% |
| 2023-04-19 | $15.15 | +6.87% | Filled | 1d | 4d | 57% | 100% | 100% | 100% |
| 2023-03-06 | $10.87 | +65.50% | Open | 5d | — | 24% | 61% | 66% | 88% |
| 2022-11-10 | $8.47 | +6.26% | Filled | 9d | 9d | 11% | 11% | 100% | 100% |
| 2022-09-13 | $12.36 | -5.10% | Open | 3d | — | 37% | 83% | 83% | 83% |
| 2022-08-03 | $9.00 | -8.67% | Filled | 2d | 2d | 23% | 100% | 100% | 100% |
| 2022-07-26 | $11.03 | +8.43% | Filled | 1d | 1d | 100% | 100% | 100% | 100% |
| 2022-06-13 | $6.66 | -6.01% | Filled | 2d | 3d | 48% | 100% | 100% | 100% |
| 2022-05-10 | $5.66 | +6.01% | Filled | 1d | 2d | 91% | 100% | 100% | 100% |
| 2021-12-28 | $11.38 | +7.03% | Filled | 15d | 17d | 15% | 15% | 15% | 100% |
| 2021-12-27 | $40.62 | -68.88% | Open | — | — | 2% | 17% | 20% | 20% |
BridgeBio Pharma (BBIO) is trading at $84.22 in premarket, up $3.92 (4.88%) from the previous close of $80.30.
BridgeBio Pharma (BBIO) is up 4.88% from its previous close in premarket trading. Premarket moves are usually driven by company-specific news, earnings results, analyst rating or price-target changes, or broad market and sector sentiment. Check the latest BBIO premarket headlines and gap history below for the likely catalyst.
Premarket trading for BBIO on the NASDAQ runs from 4:00 AM to 9:30 AM Eastern Time, ahead of the regular session (9:30 AM – 4:00 PM ET). After-hours runs from 4:00 PM to 8:00 PM ET.
Over the past 5 years, 71% of BBIO gap-ups have fully filled and 83% of gap-downs have filled. Median time to fill is 2 trading days for gap-ups and 5 trading days for gap-downs.
Yes. BBIO has 1 unfilled gap from the past 60 days. The largest is a +7.2% gap up from Jul 9, 2026 and is currently 89% retraced.
Based on 33 qualifying gap events over the past 5 years, the average 20-trading-day return after a BBIO gap up is -3.3%, and after a gap down is +11.79%.
BBIO is scheduled to report earnings on Aug 4, 2026 after the close (confirmed), with an estimated EPS of $-0.64. BridgeBio Pharma is widely expected to report its Q2 2026 financial results on August 4, 2026. While a formal press release from the company confirming this specific date was not found as of July 15, 2026, multiple major financial sources including MarketBeat, Zacks, and WallStreetZen consistently cite this date and a conference call time of 4:30 PM ET.